Medicare Enrolled

Dr. Edward Assi, D.O.

Cardiovascular Disease · El Paso, TX
Practice pattern: Electrophysiology & Cardiac— Practice combining electrophysiology and cardiac services
Speaking/Promotional
1700 CLIFF, BLDG A, El Paso, TX 79902
9155779009
In practice since 2005 (20 years)
NPI: 1669472544 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Assi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Assi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Assi

Dr. Edward Assi is a cardiovascular disease in El Paso, TX, with 20 years in practice. Based on federal Medicare data, Dr. Assi performed 4,853 Medicare services across 3,676 unique beneficiaries.

Between the years covered by Open Payments, Dr. Assi received a total of $74,484 from 45 pharmaceutical and/or device companies across 820 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Assi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 17% volume in TX$ $74,484 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,853
Medicare services
Top 17% in TX for cardiovascular disease
3,676
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~243 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Electrocardiogram (EKG), 12-lead792$9$58
Office visit, established patient (30-39 min)772$82$298
Echocardiogram, transthoracic298$133$735
Regadenoson injection (Lexiscan) for heart stress test280$43$155
Hospital follow-up visit, moderate complexity241$59$202
EKG interpretation and report240$6$30
Office visit, established patient (20-29 min)171$54$202
Nuclear medicine studies of heart muscle at rest and with stress and spect142$219$980
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician133$45$272
Remote pacemaker/defibrillator monitoring, 90 days133$15$99
Technetium tc-99m tetrofosmin, diagnostic, per study dose123$52$736
Programming of dual lead pacemaker system107$52$180
New patient office visit (45-59 min)105$103$456
Hospital follow-up visit, high complexity103$91$289
Evaluation of cardiac rhythm monitor system, remote up to 30 days95$18$81
Remote pacemaker monitoring, 90 days94$20$100
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec93$26$101
Office visit, established patient (10-19 min)73$40$122
Initial hospital admission, high complexity72$132$562
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes66$9$77
Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days54$18$70
Office visit, established patient, complex (40-54 min)54$123$401
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician52$9$45
Heart rhythm recording continous external ekg over more than 48 hours up to 7 days51$9$44
Ultrasound of both sides of head and neck blood flow49$135$701
Initial hospital admission, moderate complexity44$97$380
Programming of multiple lead implantable defibrillator system41$69$277
Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days40$22$181
Cardiac catheterization36$201$920
Nuclear medicine study of heart muscle at rest and with stress and spect35$196$864
Ultrasound of leg arteries or artery grafts25$182$866
New patient office visit, complex (60-74 min)21$144$573
Heart rhythm review and interpretation of continous external ekg over 8-15 days19$20$77
Heart rhythm recording of continous external ekg over 8-15 days18$9$44
Heart muscle strain imaging16$26$144
Programming of multiple lead pacemaker system15$55$210
Ultrasound of heart, follow-up15$18$80
Ultrasound of heart blood flow, valves and chambers15$13$57
Ultrasound of heart with color-depicted blood flow, rate and valve function15$2$11
Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel15$42$272
Replacement of aortic valve through the skin and femoral artery14$559$3,879
Hospital discharge management, 30+ min14$76$299
Ultrasound scan of abdominal aorta13$102$268
Ultrasound of heart with probe in esophagus, with report13$75$315
External shock to heart to regulate heart beat12$82$362
Ultrasound of heart12$28$135
Ultrasound study of arm or leg veins with compression and maneuvers12$125$690
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
16.6% high complexity
16.7% medium
66.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$74,484
Total received (2018-2024)
Avg $10,641/year across 7 years
Top 8% in TX for cardiovascular disease
45
Companies
820
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$37,106 (49.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$34,557 (46.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,821 (3.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,513
2023
$11,413
2022
$8,093
2021
$6,123
2020
$3,135
2019
$15,877
2018
$23,328

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$28,490
Medtronic, Inc.
$22,587
Medtronic Vascular, Inc.
$4,522
Inari Medical, Inc.
$4,018
Philips Electronics North America Corporation
$3,205
Abbott Laboratories
$2,422
ABIOMED
$2,163
Novartis Pharmaceuticals Corporation
$907
ShockWave Medical, Inc
$871
Amgen Inc.
$656
PFIZER INC.
$501
Edwards Lifesciences Corporation
$438
Penumbra, Inc.
$378
HeartFlow, Inc.
$358
Amarin Pharma Inc.
$320
Terumo Medical Corporation
$275
AstraZeneca Pharmaceuticals LP
$237
E.R. Squibb & Sons, L.L.C.
$230
Shockwave Medical, Inc
$201
Cardiovascular Systems Inc.
$181
Regeneron Healthcare Solutions, Inc.
$168
GE HEALTHCARE
$160
CVRx, Inc.
$145
Boston Scientific Corporation
$142
SANOFI-AVENTIS U.S. LLC
$139
Chiesi USA, Inc.
$133
BOSTON SCIENTIFIC CORPORATION
$100
AbbVie Inc.
$82
Gilead Sciences, Inc.
$71
Kowa Pharmaceuticals America, Inc.
$63
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$53
Boehringer Ingelheim Pharmaceuticals, Inc.
$52
Allergan Inc.
$21
Lilly USA, LLC
$21
Baxter Healthcare
$21
MEDICOMP INC
$20
Merck Sharp & Dohme Corporation
$17
Aegerion Pharmaceuticals, Inc.
$17
CHIESI USA, INC.
$16
Allergan, Inc.
$15
Astellas Pharma US Inc
$15
Xeris Pharmaceuticals, Inc.
$15
Merck Sharp & Dohme LLC
$14
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$13
Medicure Pharma Inc.
$10
Top 3 companies account for 74.6% of total payments
Associated products mentioned in payments ›
(6371) Laser CVX300 · (6399) Angio iFR · (6571) Eagle Eye · (6574) Coronary Other · (9266) ELCA · 3F · AURORA EV-ICD MRI SURESCAN · AZURE XT DR MRI SURESCAN · Advisa · Aggrastat (tirofiban HCl) · Asahi Fielder coronary guide wire · Assurity Pacemaker · BRILINTA · BYSTOLIC · Barostim Neo System · CARDIOMEMS · CHANTIX · CLARIA MRI QUAD CRT-D SURESCAN · CLEVIPREX 25MG/50ML · COBALT DR MRI SURESCAN · COREVALVE EVOLUT R · CT THROMBECTOMY SYSTEM KIT · Cardiac Monitor · CardioMEMS HF System · Cobalt · Confirm Rx · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · DALVANCE · Durata Defibrillation ICD Lead · ELIQUIS · EMGALITY · ENSITE PRECISION · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FFRct · FLOWTRIEVER CATHETER · GENERAL STRUCTURAL HEART · GENERAL - STRUCTURAL HEART · GENERAL PAIN MANAGEMENT · GUIDEZILLA · Heartrail · Hillrom - Cardiac Ambulatory Monitor · IGT D Coronary · IGT_D Coronary · IGT_D Peripheral · IVUS Systems · Impella · JARDIANCE · JUXTAPID · KENGREAL · KEVEYIS · LEXISCAN · LINQ II · LifeVest · Livalo · MICRA · MYCARELINK · Merlin Connectivity and Remote · Micra · ONYX FRONTIER · PLASMABLADE(TM) · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pacemakers · Penumbra System · Proclaim Family of SCS IPGs · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · Quartet CRT Lead · RESOLUTE ONYX · ROTAPRO · Repatha · Resolute · Reveal LINQ · S · SELECTSECURE · SELECTSITE · SHOCKWAVE INTRAVASCULAR LITHOTRIPSY (IVL) SYSTEM WITH THE SHOCKWAVE C2+ CORONARY · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYMPLICITY G3 · SYNERGY · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave C2+ Coronary · Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripher · Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave M5+ · TEFLARO · TELESCOPE · TR Band · Unify Assura CRT Defibrillator · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN Access System · XARELTO · XIFAXAN · Xience Alpine cornary stent system · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (50%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for cardiovascular disease in TX.

Equivalent to $1,535 per 100 Medicare services performed
Looking for a cardiovascular disease in El Paso?
Compare cardiovascular diseases in the El Paso area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
34
Per 100K population
3.9
County median income
$58,859
Nearest hospital
THE HOSPITALS OF PROVIDENCE - MEMORIAL CAMPUS
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Assi is a electrophysiology & cardiac specialist, with above-average Medicare volume (top 17% in TX), and high industry engagement (speaking/promotional, top 8%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Assi experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Assi performed 792 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Assi receive payments from pharmaceutical companies?
Yes. Dr. Assi received a total of $74,484 from 45 companies across 820 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Assi's costs compare to other cardiovascular diseases in El Paso?
Dr. Assi's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Assi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →